Cutler Group LP Rocket Pharmaceuticals, Inc. Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Cutler Group LP holds 8,000 shares of RCKT stock, worth $80,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,000
Previous 100
7900.0%
Holding current value
$80,880
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RCKT
# of Institutions
222Shares Held
93.1MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$179 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$114 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$66.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$62.6 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.71MShares$47.7 Million0.27% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $765M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...